Page last updated: 2024-11-04

tazarotene and Keratoacanthoma

tazarotene has been researched along with Keratoacanthoma in 4 studies

tazarotene: a topical acetylenic retinoid; a topical kerytolytic
tazarotene : The ethyl ester of tazarotenic acid. A prodrug for tazarotenic acid, it is used for the treatment of psoriasis, acne, and sun-damaged skin.

Keratoacanthoma: A benign, non-neoplastic, usually self-limiting epithelial lesion closely resembling squamous cell carcinoma clinically and histopathologically. It occurs in solitary, multiple, and eruptive forms. The solitary and multiple forms occur on sunlight exposed areas and are identical histologically; they affect primarily white males. The eruptive form usually involves both sexes and appears as a generalized papular eruption.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Giberson, M1
Rogachefsky, A1
Lortie, C1
Paolino, G1
Muscardin, LM1
Donati, M1
Didona, D1
Panetta, C1
Donati, P1
Resnik, KS1
Kutzner, H1
Feldman, RJ1
Maize, JC1

Reviews

1 review available for tazarotene and Keratoacanthoma

ArticleYear
Multiple keratoacanthomas in a young woman: report of a case emphasizing medical management and a review of the spectrum of multiple keratoacanthomas.
    International journal of dermatology, 2007, Volume: 46, Issue:1

    Topics: Acitretin; Adult; Biopsy; Female; Humans; Isotretinoin; Keratoacanthoma; Keratolytic Agents; Nicotin

2007

Other Studies

3 other studies available for tazarotene and Keratoacanthoma

ArticleYear
Finding Chemo for Nemo: Recurrent Eruptive Keratoacanthomas in a Tattoo.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2020, Volume: 46, Issue:12

    Topics: Administration, Cutaneous; Biopsy; Combined Modality Therapy; Cryotherapy; Female; Humans; Keratoaca

2020
Complete regression of keratoacanthoma with topical tazarotene gel 0.1%: therapeutic and pathophysiological perspectives.
    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2019, Volume: 154, Issue:2

    Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Dermatologic Agents; Female; Gels; Humans; Kerat

2019
Mimicry illuminating pitfalls in histopathologic diagnosis: nutritional deficiency-like dermatitis secondary to topical tazarotene and keratoacanthomatous pseudocarcinomatous hyperplasia in CD30+ lymphoproliferative disorder as illustrative.
    The American Journal of dermatopathology, 2009, Volume: 31, Issue:1

    Topics: Adolescent; Child; Dermatitis; Dermatologic Agents; Diagnosis, Differential; Female; Humans; Hyperpl

2009